Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Callaghan

Showing results (311-320 of 320) with videos related to

Pageof 32
Sort By:
You have reached the last page of results.This site can display upto 320 results.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2025
PARP inhibitors potentiate proton therapy end-of-range effects by accelerating replication forks and promoting transcription conflictYiqun Han, Qin Zhou, Anna Dibbs, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2022
Manipulation of Redox Metabolism Using Pharmacologic Ascorbate Opens a Therapeutic Window for Radio-Sensitization by ATM Inhibitors in Colorectal CancerCameron M Callaghan, Ibrahim M Abukhiran, Amr Masaadeh, et al.
Cancers|August 19, 2020
Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective AgentsCameron M Callaghan, M M Hasibuzzaman, Samuel N Rodman, et al.
Cell Death & Disease|April 4, 2024
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJean-Louis A Parmasad, Konrad M Ricke, Benjamin Nguyen, et al.
Molecular Cancer Therapeutics|January 15, 2024
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis XenograftsJianxiong Ji, Sonja Dragojevic, Cameron M Callaghan, et al.
JAMA|April 22, 2010
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United StatesAlicia M Siston, Sonja A Rasmussen, Margaret A Honein, et al.
BMC Musculoskeletal Disorders|September 28, 2017
Protocol for a multi-centre randomised controlled trial comparing arthroscopic hip surgery to physiotherapy-led care for femoroacetabular impingement (FAI): the Australian FASHIoN trialNicholas J Murphy, Jillian Eyles, Kim L Bennell, et al.
Molecular Cancer Therapeutics|October 23, 2024
DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway DeficitsSonja Dragojevic, Emily J Smith, Michael S Regan, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridineJin Li, Kristin M Lundy DeMello, Henry Cheng, et al.
Molecular Ecology|October 12, 2013
Towards a unified paradigm for sequence-based identification of fungiUrmas Kõljalg, R Henrik Nilsson, Kessy Abarenkov, et al.
Pageof 32

Showing results (311-320 of 320) with videos related to

Sort By:
Pageof 32
You have reached the last page of results.This site can display upto 320 results.
International Journal of Radiation Oncology, Biology, Physics|August 29, 2025
PARP inhibitors potentiate proton therapy end-of-range effects by accelerating replication forks and promoting transcription conflictYiqun Han, Qin Zhou, Anna Dibbs, et al.
International Journal of Radiation Oncology, Biology, Physics|October 13, 2022
Manipulation of Redox Metabolism Using Pharmacologic Ascorbate Opens a Therapeutic Window for Radio-Sensitization by ATM Inhibitors in Colorectal CancerCameron M Callaghan, Ibrahim M Abukhiran, Amr Masaadeh, et al.
Cancers|August 19, 2020
Neoadjuvant Radiotherapy-Related Wound Morbidity in Soft Tissue Sarcoma: Perspectives for Radioprotective AgentsCameron M Callaghan, M M Hasibuzzaman, Samuel N Rodman, et al.
Cell Death & Disease|April 4, 2024
Genetic and pharmacological reduction of CDK14 mitigates synucleinopathyJean-Louis A Parmasad, Konrad M Ricke, Benjamin Nguyen, et al.
Molecular Cancer Therapeutics|January 15, 2024
Differential Distribution of the DNA-PKcs Inhibitor Peposertib Selectively Radiosensitizes Patient-derived Melanoma Brain Metastasis XenograftsJianxiong Ji, Sonja Dragojevic, Cameron M Callaghan, et al.
JAMA|April 22, 2010
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United StatesAlicia M Siston, Sonja A Rasmussen, Margaret A Honein, et al.
BMC Musculoskeletal Disorders|September 28, 2017
Protocol for a multi-centre randomised controlled trial comparing arthroscopic hip surgery to physiotherapy-led care for femoroacetabular impingement (FAI): the Australian FASHIoN trialNicholas J Murphy, Jillian Eyles, Kim L Bennell, et al.
Molecular Cancer Therapeutics|October 23, 2024
DNA-PK Inhibition Shows Differential Radiosensitization in Orthotopic GBM PDX Models Based on DDR Pathway DeficitsSonja Dragojevic, Emily J Smith, Michael S Regan, et al.
Bioorganic & Medicinal Chemistry Letters|December 20, 2003
Discovery of a potent, selective and orally active canine COX-2 inhibitor, 2-(3-difluoromethyl-5-phenyl-pyrazol-1-yl)-5-methanesulfonyl-pyridineJin Li, Kristin M Lundy DeMello, Henry Cheng, et al.
Molecular Ecology|October 12, 2013
Towards a unified paradigm for sequence-based identification of fungiUrmas Kõljalg, R Henrik Nilsson, Kessy Abarenkov, et al.
Pageof 32